NLRP3 and Hepatic fibrosis: These results were consistent with multiple mouse model studies, in which ASK1 inhibition attenuated cell death and liver fibrosis in mouse models with liver injury caused by NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome activation [67].